Atherosclerosis ID'd in Many Without CV Risk Factors

Share this content:
Atherosclerosis ID'd in Many Without CV Risk Factors
Atherosclerosis ID'd in Many Without CV Risk Factors

TUESDAY, Dec. 12, 2017 (HealthDay News) -- Many individuals without cardiovascular risk factors (CVRFs) have atherosclerosis, with low-density lipoprotein cholesterol (LDL-C) independently associated with the presence and extent of atherosclerosis, according to a study published in the Dec. 19 issue of the Journal of the American College of Cardiology.

Leticia Fernández-Friera, M.D., Ph.D., from the Centro Nacional de Investigaciones Cardiovasculares Carlos III in Madrid, and colleagues examined predictors of subclinical atherosclerosis in CVRF-free individuals. A total of 1,779 participants from the Progression of Early Subclinical Atherosclerosis study without conventional CVRFs (45.0 ± 4.1 years; 50.3 percent women) were assessed. A subgroup of 740 patients had optimal CVRFs.

The researchers found that 49.7 percent of CVRF-free participants had subclinical atherosclerosis (plaque or coronary artery calcification). In addition to male sex and age, LDL-C was independently associated with the presence and extent of atherosclerosis in the CVRF-free and CVRF-optimal groups (odds ratio, 1.14 to 1.18). The presence and extent of atherosclerosis was also associated with glycosylated hemoglobin levels in the CVRF-free group.

"Many CVRF-free middle-aged individuals have atherosclerosis. LDL-C, even at levels currently considered normal, is independently associated with the presence and extent of early systemic atherosclerosis in the absence of major CVRFs," the authors write. "These findings support more effective LDL-C lowering for primordial prevention, even in individuals conventionally considered at optimal risk."

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »